Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Strides Shasun

Strides Shasun

BSE: 532531|NSE: STAR|ISIN: INE939A01011|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 24, 12:04
1089.30
9.85 (0.91%)
VOLUME 21,326
LIVE
NSE
Jul 24, 12:01
1089.25
8.75 (0.81%)
VOLUME 157,566
News on Strides Shasun
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Strides Shasun up 2% on USFDA approval for Cetirizine Hydrochloride capsules

12.00 pm | 24 Jul 2017 |  Source: Moneycontrol.com

The product will be manufactured at the company's flagship facility at Bangalore and marketed by Strides Pharma, Inc in the US market....

Strides Shasun receives USFDA approval for Cetirizine Softgel capsules

8.58 am | 24 Jul 2017 |  Source: Moneycontrol.com

Strides Shasun has received approval from United States Food & Drug Administration (USFDA) for Cetirizine Hydrochloride capsules, 10 mg....

Key resistance for Nifty at 9969; 4 stocks to buy today: Prakash Gaba 

8.15 am | 24 Jul 2017 |  Source: Moneycontrol.com

According to Prakash Gaba of prakashgaba.com, the next logical technical target for the Nifty is at 9969. The crucial support for the Index is at 9792...

Remain bullish about performance overall in FY18: Strides Shasun 

12.33 pm | 17 Jul 2017 |  Source: CNBC-TV18

Strides Shasun may receive approval for Lovaza generic, which has a market size of around USD 750-800 million in the United Sates and could make upto ...

Sequent Scientific gets CCI approval for Scheme of Arrangement 

2.26 pm | 03 Jul 2017 |  Source: CNBC-TV18

Competition Commission of India (CCI) approves Scheme of Arrangement between Strides Shasun, Sequent Scientific and Solara Active Pharma Sciences. In ...

Strides Shasun gets USFDA go-ahead for anti-allergy drug

11.45 am | 03 Jul 2017 |  Source: PTI

The product will be manufactured at the company's Bengaluru facility and marketed by Strides Pharma Inc in the US market....

Strides Shasun gains 1% on USFDA approval for Promethazine Hydrochloride tablets

9.29 am | 03 Jul 2017 |  Source: Moneycontrol.com

The company has received approval from the United States Food & Drug Administration (USFDA) for Promethazine Hydrochloride tablets USP, 12.5 mg, 25 mg...

Strides Shasun receives USFDA approval for Promethazine Hydrochloride tablets

8.50 am | 03 Jul 2017 |  Source: Moneycontrol.com

Strides Shasun has received approval from the United States Food & Drug Administration (USFDA) for Promethazine Hydrochloride Tablets USP, 12.5 mg, 25...

Buy Strides Shasun; target of Rs 1,200: Axis Direct

1.39 pm | 27 Jun 2017 |  Source: Moneycontrol.com

Axis Direct is bullish on Strides Shasun has recommended buy rating on the stock with a target price of Rs 1,200 in its research report dated Jun 22, ...

Strides Shasun completes JV with Vivimed Lab in India & Singapore

11.03 am | 22 Jun 2017 |  Source: Moneycontrol.com

Strides Shasun has signed definitive agreements with Vivimed Lab....

Buy Strides Shasun; target of Rs 1340: Axis Direct

1.52 pm | 20 Feb 2017 |  Source: Moneycontrol.com

Axis Direct is bullish on Strides Shasun has recommended buy rating on the stock with a target price of Rs 1340 in its research report dated February ...

Border tax counter productive for US, may never happen: Strides 

2.30 pm | 07 Feb 2017 |  Source: CNBC-TV18

Going forward, the pharma company is going to to focus on its B2C business and the high cash generating verticals, he says....

Strides Shasun Q3 profit up 3-fold, divestment income supports

2.46 pm | 03 Feb 2017 |  Source: Moneycontrol.com

Bangalore-based Healthcare firm Strides Shasun has reported a massive 3-fold jump in third quarter consolidated profit at Rs 187.3 crore compared with...

1 2
Quick Links for Strides Shasun
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.